Nucleus Software Exports Ltd
NSE:NUCLEUS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nucleus Software Exports Ltd
NSE:NUCLEUS
|
IN |
|
F
|
Fresenius Medical Care AG
SWB:FME
|
DE |
|
Black Box Ltd
NSE:BBOX
|
IN |
|
Adient PLC
NYSE:ADNT
|
IE |
|
M K Proteins Ltd
NSE:MKPL
|
IN |
|
B
|
Bristol-Myers Squibb Co
XHAM:BRM
|
US |
|
Eagle Materials Inc
NYSE:EXP
|
US |
|
Jardine Cycle & Carriage Ltd
SGX:C07
|
SG |
|
L
|
Liaoning Cheng Da Co Ltd
SSE:600739
|
CN |
Wall St Price Targets
NUCLEUS Price Targets Summary
Nucleus Software Exports Ltd
According to Wall Street analysts, the average 1-year price target for NUCLEUS is 1 224 INR with a low forecast of 1 212 INR and a high forecast of 1 260 INR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NUCLEUS's stock price target?
Price Target
1 224
INR
According to Wall Street analysts, the average 1-year price target for NUCLEUS is 1 224 INR with a low forecast of 1 212 INR and a high forecast of 1 260 INR.
What is the Revenue forecast for Nucleus Software Exports Ltd?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is 8%.
What is the Operating Income forecast for Nucleus Software Exports Ltd?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 3 years is 5%.
What is the Net Income forecast for Nucleus Software Exports Ltd?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 3 years is 4%.
